Phenytoin-induced Changes in the Pharmacokinetics of Misonidazole in Radiotherapy Patients

Overview

Journal Br J Cancer

Specialty Oncology

Date 1981 Oct 1

PMID 7295516

Citations 3

Authors

J L Moore

I C Paterson

H Newman

S Venables

Affiliations

Soon will be listed here.

Citing Articles

The role of dexamethasone in the modification of misonidazole pharmacokinetics.

Jones D, Bleehen N, Workman P, Walton M Br J Cancer. 1983; 48(4):553-7.

PMID: 6626454 PMC: 2011507. DOI: 10.1038/bjc.1983.228.

Misonidazole neurotoxicity in rats: Part II. Effect of pre- and intermittent treatment with pentobarbital on misonidazole neurotoxicity in the rat.

Edwards M, Gordon D, Salamy A, Levin V, Phillips T J Neurooncol. 1984; 2(2):95-8.

PMID: 6481429

Pharmacokinetic drug interactions with phenytoin (Part II).

Nation R, Evans A, Milne R Clin Pharmacokinet. 1990; 18(2):131-50.

PMID: 2180613 DOI: 10.2165/00003088-199018020-00004.

References

Dische S, Saunders M, Lee M, Adams G, Flockhart I . Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977; 35(5):567-79. PMC: 2025511. DOI: 10.1038/bjc.1977.90. View

McNally N, Denekamp J, Sheldon P, Flockhart I, Stewart F . Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. Radiat Res. 1978; 73(3):568-80. View

Workman P, Little C, Marten T, DALE A, Ruane R, Flockhart I . Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography. J Chromatogr. 1978; 145(3):507-12. DOI: 10.1016/s0378-4347(00)81386-9. View

Urtasun R, Chapman J, Feldstein M, Band R, Rabin H, Wilson A . Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer Suppl. 1978; 3:271-5. PMC: 2149411. View

Ash D, Smith M, Bugden R . Distribution of misonidazole in human tumours and normal tissues. Br J Cancer. 1979; 39(5):503-9. PMC: 2009904. DOI: 10.1038/bjc.1979.93. View

Wasserman T, Phillips T, Johnson R, Gomer C, Lawrence G, Sadee W . Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys. 1979; 5(6):775-86. DOI: 10.1016/0360-3016(79)90061-0. View

Paterson I, Dawes P, Henk J, Moore J . Pilot study of radiotherapy with misonidazole in head and neck cancer. Clin Radiol. 1981; 32(2):225-9. DOI: 10.1016/s0009-9260(81)80166-3. View

Workman P . Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer. 1979; 40(3):335-53. PMC: 2010042. DOI: 10.1038/bjc.1979.187. View

Workman P, Bleehen N, Wiltshire C . Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity. Br J Cancer. 1980; 41(2):302-4. PMC: 2010192. DOI: 10.1038/bjc.1980.43. View

10.

Wasserman T, Phillips T, Van Raalte G, Urtasun R, Partington J, Koziol D . The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol. 1980; 53(626):172-3. DOI: 10.1259/0007-1285-53-626-172. View

11.

White R, Workman P . Phenytoin sodium-induced alterations in the pharmacokinetics of misonidazole in the dog. Cancer Treat Rep. 1980; 64(2-3):360-1. View

12.

Brown J, Yu N . The optimum time for irradiation relative to tumour concentration of hypoxic cell sensitizers. Br J Radiol. 1980; 53(633):915-6. DOI: 10.1259/0007-1285-53-633-915. View

13.

Dische S, Saunders M, Flockhart I, Lee M, Anderson P . Misonidazole-a drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys. 1979; 5(6):851-60. DOI: 10.1016/0360-3016(79)90070-1. View